NO20006039L - Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin - Google Patents

Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin

Info

Publication number: NO20006039L
Authority: NO; Norway
Prior art keywords: carboxyamino; tetrahydroquinoline; substituted; preparation
Prior art date: 1999-11-30

Application number

NO20006039A

Other languages

English (en)

Norwegian (no)

Other versions

NO20006039D0 (no

Inventor

David Burns Damon

Robert Wayne Dugger

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-30

Filing date

2000-11-29

Publication date

2001-05-31

2000-11-29 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-11-29 Publication of NO20006039D0 publication Critical patent/NO20006039D0/no

2001-05-31 Publication of NO20006039L publication Critical patent/NO20006039L/no

Links

-1 4-Carboxyamino-2-Substituted-1,2,3,4-Tetrahydroquinoline Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Quinoline Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20006039A 1999-11-30 2000-11-29 Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin NO20006039L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US16796799P	1999-11-30	1999-11-30

Publications (2)

Publication Number	Publication Date
NO20006039D0 NO20006039D0 (no)	2000-11-29
NO20006039L true NO20006039L (no)	2001-05-31

Family

ID=22609556

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20006039A NO20006039L (no)	1999-11-30	2000-11-29	Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin

Country Status (44)

Country	Link
US (1)	US6313142B1 (fr)
EP (1)	EP1125929B1 (fr)
JP (1)	JP3579345B2 (fr)
KR (1)	KR100408177B1 (fr)
CN (1)	CN1173953C (fr)
AP (1)	AP2000002011A0 (fr)
AR (1)	AR029775A1 (fr)
AT (1)	ATE315028T1 (fr)
AU (1)	AU784694B2 (fr)
BG (1)	BG105009A (fr)
BR (1)	BR0005636A (fr)
CA (1)	CA2327029C (fr)
CO (1)	CO5261552A1 (fr)
CY (1)	CY1104989T1 (fr)
CZ (1)	CZ20004407A3 (fr)
DE (1)	DE60025317T2 (fr)
DK (1)	DK1125929T3 (fr)
DZ (1)	DZ3079A1 (fr)
EA (1)	EA003668B1 (fr)
EE (1)	EE200000659A (fr)
ES (1)	ES2254109T3 (fr)
GE (1)	GEP20022798B (fr)
GT (1)	GT200000190A (fr)
HN (1)	HN2000000203A (fr)
HR (1)	HRP20000804A2 (fr)
HU (1)	HUP0004747A3 (fr)
ID (1)	ID28489A (fr)
IL (1)	IL139849A (fr)
IS (1)	IS5715A (fr)
MA (1)	MA25223A1 (fr)
NO (1)	NO20006039L (fr)
NZ (1)	NZ508509A (fr)
OA (1)	OA11494A (fr)
PA (1)	PA8503801A1 (fr)
PE (1)	PE20010913A1 (fr)
PL (1)	PL344208A1 (fr)
SG (1)	SG102603A1 (fr)
SK (1)	SK17792000A3 (fr)
TN (1)	TNSN00230A1 (fr)
TW (1)	TW591016B (fr)
UA (1)	UA65615C2 (fr)
UY (1)	UY26451A1 (fr)
YU (1)	YU71500A (fr)
ZA (1)	ZA200006947B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HN2000000203A (es) *	1999-11-30	2001-06-13	Pfizer Prod Inc	Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
MXPA04005864A (es) *	2001-12-19	2004-10-29	Atherogenics Inc	Derivados de charcona y su uso para tratar enfermedades.
WO2003053359A2 (fr)	2001-12-19	2003-07-03	Atherogenics, Inc.	1,3-bis-(phenyl-substitue)-2-propyne-1-ones et leur utilisation pour le traitement d'affections
CA2480439C (fr) *	2002-04-11	2012-08-21	Roar Holding Llc	Procede ex vivo permettant de determiner l'activite de cetp et l'efficacite d'un traitement d'une cardiopathie
US7504508B2 (en) *	2002-10-04	2009-03-17	Millennium Pharmaceuticals, Inc.	PGD2 receptor antagonists for the treatment of inflammatory diseases
US20090181966A1 (en) *	2002-10-04	2009-07-16	Millennium Pharmaceuticals, Inc.	PGD2 receptor antagonists for the treatment of inflammatory diseases
MXPA05003456A (es) *	2002-10-04	2005-07-05	Millennium Pharm Inc	Antagonistas del receptor de pgd2 para el tratamiento de enfermedades inflamatorias.
US7223870B2 (en) *	2002-11-01	2007-05-29	Pfizer Inc.	Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
AU2003303239A1 (en) *	2002-12-19	2004-07-14	Atherogenics, Inc.	Process of making chalcone derivatives
ATE407670T1 (de)	2002-12-20	2008-09-15	Pfizer Prod Inc	Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer
US20040132771A1 (en) *	2002-12-20	2004-07-08	Pfizer Inc	Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
EP1601655A2 (fr) *	2003-03-04	2005-12-07	Takasago International Corporation	Procede de production d'amines optiquement actives
CA2519458A1 (fr) *	2003-03-17	2004-09-30	Japan Tobacco Inc.	Procede pour accroitre la biodisponibilite orale de s- 2-( '1-(2-ethylbutyl)cyclohexyl!carbonyl!amino)phenyl!-2-methylpropanethioate
PL1603553T3 (pl) *	2003-03-17	2012-04-30	Japan Tobacco Inc	Kompozycje farmaceutyczne inhibitorów CETP
TWI494102B (zh) *	2003-05-02	2015-08-01	Japan Tobacco Inc	包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
BRPI0414186A (pt) *	2003-10-08	2006-10-31	Lilly Co Eli	compostos, métodos de antagonizar a atividade de cetp, de tratar ou prevenir uma doença, de diminuir o colesterol ldl plasmático em um mamìmero, de tratar e/ou prevenir seqüelas patológicas, formulação farmacêutica, e, uso de um composto
UA90269C2 (ru) *	2004-04-02	2010-04-26	Мицубиси Танабе Фарма Корпорейшн	Тетрагидрохинолиновые производные и способ их получения
CA2570688A1 (fr) *	2004-06-24	2006-02-02	Eli Lilly And Company	Composes et procedes destines a traiter la dyslipidemie
DOP2005000123A (es) *	2004-07-02	2011-07-15	Merck Sharp & Dohme	Inhibidores de cetp
WO2006033001A1 (fr) *	2004-09-23	2006-03-30	Pfizer Products Inc.	Composes de quinoline
US7700774B2 (en) *	2004-12-20	2010-04-20	Dr. Reddy's Laboratories Ltd.	Heterocyclic compounds and their pharmaceutical compositions
AU2006216713A1 (en) *	2005-02-24	2006-08-31	Millennium Pharmaceuticals, Inc.	PGD2 receptor antagonists for the treatment of inflammatory diseases
TW200808731A (en)	2006-03-30	2008-02-16	Tanabe Seiyaku Co	A process for preparing tetrahydroquinoline derivatives
AR065670A1 (es)	2007-03-09	2009-06-24	Indigene Pharmaceuticals Inc	Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas
CN101429160B (zh) *	2007-11-06	2011-10-19	上海药明康德新药开发有限公司	一种1-r-4-氨基-1,2,3,4-四氢喹啉的合成方法
TWI450896B (zh) *	2009-06-30	2014-09-01	Lilly Co Eli	反式－４－〔〔（５ｓ）－５－〔〔〔３，５－雙（三氟甲基）苯基〕甲基〕（２－甲基－２ｈ－四唑－５－基）胺基〕－２，３，４，５－四氫－７，９－二甲基－１ｈ－１－苯并氮呯－１－基〕甲基〕－環己基羧酸
MA71399A (fr)	2022-07-05	2025-04-30	Newamsterdam Pharma B.V.	Sels d'obicetrapib et leurs procédé de fabrication et leurs intermédiaires

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR7870M (fr) *	1968-11-08	1970-04-27
US3971789A (en)	1972-10-21	1976-07-27	John Wyeth & Brother Limited	O-(4-Quinolylamino)benzamides
GB8432091D0 (en)	1984-12-19	1985-01-30	Wyeth John & Brother Ltd	4-aminoquinoline derivatives
US4839368A (en)	1986-05-02	1989-06-13	Mochida Pharmaceutical Co., Ltd.	1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
GB8804444D0 (en)	1988-02-25	1988-03-23	Smithkline Beckman Intercredit	Compounds
US5231102A (en)	1989-03-08	1993-07-27	Merck Sharp & Dohme, Ltd.	Tetrahydroquinoline derivatives useful for neurodegenerative disorders
PT100905A (pt) *	1991-09-30	1994-02-28	Eisai Co Ltd	Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6140342A (en)	1998-09-17	2000-10-31	Pfizer Inc.	Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6147089A (en)	1998-09-17	2000-11-14	Pfizer Inc.	Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
US6197786B1 (en) *	1998-09-17	2001-03-06	Pfizer Inc	4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
HN2000000203A (es) *	1999-11-30	2001-06-13	Pfizer Prod Inc	Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.

2000
- 2000-09-14 HN HN2000000203A patent/HN2000000203A/es unknown
- 2000-09-27 PA PA20008503801A patent/PA8503801A1/es unknown
- 2000-09-29 OA OA1200000268A patent/OA11494A/en unknown
- 2000-10-10 US US09/684,830 patent/US6313142B1/en not_active Expired - Fee Related
- 2000-11-03 GT GT200000190A patent/GT200000190A/es unknown
- 2000-11-09 CO CO00085289A patent/CO5261552A1/es not_active Application Discontinuation
- 2000-11-13 AT AT00310064T patent/ATE315028T1/de not_active IP Right Cessation
- 2000-11-13 DE DE60025317T patent/DE60025317T2/de not_active Expired - Fee Related
- 2000-11-13 ES ES00310064T patent/ES2254109T3/es not_active Expired - Lifetime
- 2000-11-13 DK DK00310064T patent/DK1125929T3/da active
- 2000-11-13 EP EP00310064A patent/EP1125929B1/fr not_active Expired - Lifetime
- 2000-11-16 YU YU71500A patent/YU71500A/sh unknown
- 2000-11-17 IS IS5715A patent/IS5715A/is unknown
- 2000-11-22 HR HR20000804A patent/HRP20000804A2/hr not_active Application Discontinuation
- 2000-11-23 IL IL139849A patent/IL139849A/en not_active IP Right Cessation
- 2000-11-23 AU AU71789/00A patent/AU784694B2/en not_active Ceased
- 2000-11-24 TW TW089125066A patent/TW591016B/zh not_active IP Right Cessation
- 2000-11-24 SK SK1779-2000A patent/SK17792000A3/sk unknown
- 2000-11-27 ID IDP20001022D patent/ID28489A/id unknown
- 2000-11-27 CZ CZ20004407A patent/CZ20004407A3/cs unknown
- 2000-11-27 UY UY26451A patent/UY26451A1/es not_active Application Discontinuation
- 2000-11-27 ZA ZA200006947A patent/ZA200006947B/xx unknown
- 2000-11-28 SG SG200006869A patent/SG102603A1/en unknown
- 2000-11-28 PE PE2000001266A patent/PE20010913A1/es not_active Application Discontinuation
- 2000-11-28 CN CNB001283820A patent/CN1173953C/zh not_active Expired - Fee Related
- 2000-11-28 UA UA2000116782A patent/UA65615C2/uk unknown
- 2000-11-28 CA CA002327029A patent/CA2327029C/fr not_active Expired - Fee Related
- 2000-11-29 JP JP2000362153A patent/JP3579345B2/ja not_active Expired - Fee Related
- 2000-11-29 AR ARP000106287A patent/AR029775A1/es unknown
- 2000-11-29 HU HU0004747A patent/HUP0004747A3/hu unknown
- 2000-11-29 NZ NZ508509A patent/NZ508509A/en unknown
- 2000-11-29 DZ DZ000153A patent/DZ3079A1/fr active
- 2000-11-29 EA EA200001129A patent/EA003668B1/ru not_active IP Right Cessation
- 2000-11-29 KR KR10-2000-0071527A patent/KR100408177B1/ko not_active Expired - Fee Related
- 2000-11-29 TN TNTNSN00230A patent/TNSN00230A1/fr unknown
- 2000-11-29 MA MA26112A patent/MA25223A1/fr unknown
- 2000-11-29 NO NO20006039A patent/NO20006039L/no not_active Application Discontinuation
- 2000-11-30 GE GEAP20005651A patent/GEP20022798B/en unknown
- 2000-11-30 EE EEP200000659A patent/EE200000659A/xx unknown
- 2000-11-30 PL PL00344208A patent/PL344208A1/xx not_active Application Discontinuation
- 2000-11-30 BR BR0005636-7A patent/BR0005636A/pt not_active Application Discontinuation
- 2000-11-30 AP APAP/P/2000/002011A patent/AP2000002011A0/en unknown
- 2000-11-30 BG BG105009A patent/BG105009A/xx unknown
2006
- 2006-03-01 CY CY20061100287T patent/CY1104989T1/el unknown

Also Published As

Publication number	Publication date
NZ508509A (en)	2001-06-29
PA8503801A1 (es)	2002-07-30
EE200000659A (et)	2001-08-15
CA2327029A1 (fr)	2001-05-30
IL139849A0 (en)	2002-02-10
CZ20004407A3 (cs)	2002-06-12
HN2000000203A (es)	2001-06-13
GEP20022798B (en)	2002-09-25
HU0004747D0 (fr)	2001-02-28
EP1125929A1 (fr)	2001-08-22
CO5261552A1 (es)	2003-03-31
CA2327029C (fr)	2005-08-09
NO20006039D0 (no)	2000-11-29
YU71500A (sh)	2003-02-28
DE60025317T2 (de)	2006-08-03
SG102603A1 (en)	2004-03-26
KR100408177B1 (ko)	2003-12-01
US6313142B1 (en)	2001-11-06
EP1125929B1 (fr)	2006-01-04
EA003668B1 (ru)	2003-08-28
DK1125929T3 (da)	2006-04-03
TNSN00230A1 (fr)	2005-11-10
PE20010913A1 (es)	2001-09-10
JP2001163859A (ja)	2001-06-19
DZ3079A1 (fr)	2004-10-24
ID28489A (id)	2001-05-31
ATE315028T1 (de)	2006-02-15
SK17792000A3 (sk)	2002-10-08
HUP0004747A2 (hu)	2001-10-28
AU7178900A (en)	2001-05-31
KR20010052012A (ko)	2001-06-25
HK1038007A1 (en)	2002-03-01
CN1173953C (zh)	2004-11-03
UY26451A1 (es)	2001-06-29
IL139849A (en)	2006-10-31
BR0005636A (pt)	2001-07-17
TW591016B (en)	2004-06-11
GT200000190A (es)	2002-04-27
OA11494A (en)	2004-05-07
MA25223A1 (fr)	2001-07-02
AU784694B2 (en)	2006-06-01
CY1104989T1 (el)	2010-03-03
EA200001129A2 (ru)	2001-06-25
PL344208A1 (en)	2001-06-04
UA65615C2 (uk)	2004-04-15
IS5715A (is)	2001-05-31
HRP20000804A2 (en)	2001-06-30
AP2000002011A0 (en)	2000-12-31
HUP0004747A3 (en)	2002-12-28
ES2254109T3 (es)	2006-06-16
EA200001129A3 (ru)	2001-10-22
BG105009A (en)	2001-11-30
ZA200006947B (en)	2002-05-27
DE60025317D1 (de)	2006-03-30
CN1302800A (zh)	2001-07-11
JP3579345B2 (ja)	2004-10-20
AR029775A1 (es)	2003-07-16

Legal Events

Date	Code	Title	Description
2006-06-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20006039L (no)	2001-05-31	Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin
NO20015017L (no)	2001-10-15	Fremgangsmate for fremstilling av citalopram
NO20010318D0 (no)	2001-01-19	Fremgangsmåte for fremstilling av Citalopram
NO20010319D0 (no)	2001-01-19	Fremgangsmåte for fremstilling av Citalopram
ID28601A (id)	2001-06-14	Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
NO20003454D0 (no)	2000-07-04	FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO20013407D0 (no)	2001-07-10	Fremgangsmåte for fremstilling av kinolinkarbaldehyd
NO20000456D0 (no)	2000-01-28	Fremgangsmåte for fremstilling av 1,2-dikloretan
NO20020059L (no)	2002-03-04	Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20000965D0 (no)	2000-02-25	Fremgangsmåte for fremstilling av veksthormon-utskillende forbindelser
NO20021727L (no)	2002-04-12	Fremgangsmåte for fremstilling av 3,4-metylen-dioksy- mandelisk syre
NO20013995L (no)	2001-10-17	Fremgangsmåte for fremstilling av L-sorbose
HUP0300703A3 (en)	2005-01-28	Process for the preparation of quinoline derivatives
NO20014383L (no)	2001-11-02	Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
NO20011652D0 (no)	2001-04-02	Fremgangsmåte for fremstilling av 1,5-diaryl-3-substituerte pyrazoler
NO20022956L (no)	2002-06-19	Fremgangsmate for fremstilling av nitroguanidin
NO20012811D0 (no)	2001-06-07	Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20023702D0 (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20013044D0 (no)	2001-06-19	Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20005818L (no)	2000-11-17	Forbedret fremgangsmåte for fremstilling av farmasöytisk verdifulle norbenzomorfan-derivater
NO20020327D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20020670L (no)	2002-04-15	Fremgangsmåte for fremstilling av kinolin-5,8-dioner
NO20005743D0 (no)	2000-11-13	Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- oksyglukoronider
NO20002558D0 (no)	2000-05-18	FremgangsmÕte for fremstilling av findisperse eksplosivstoffer